These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25576220)

  • 1. MicroRNA-124 regulates glucocorticoid sensitivity by targeting phosphodiesterase 4B in diffuse large B cell lymphoma.
    Kim J; Jeong D; Nam J; Aung TN; Gim JA; Park KU; Kim SW
    Gene; 2015 Mar; 558(1):173-80. PubMed ID: 25576220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene set enrichment analysis unveils the mechanism for the phosphodiesterase 4B control of glucocorticoid response in B-cell lymphoma.
    Kim SW; Rai D; Aguiar RC
    Clin Cancer Res; 2011 Nov; 17(21):6723-32. PubMed ID: 21742807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase 4B is an effective therapeutic target in colorectal cancer.
    Kim DU; Kwak B; Kim SW
    Biochem Biophys Res Commun; 2019 Jan; 508(3):825-831. PubMed ID: 30528730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phosphodiesterase PDE4B limits cAMP-associated PI3K/AKT-dependent apoptosis in diffuse large B-cell lymphoma.
    Smith PG; Wang F; Wilkinson KN; Savage KJ; Klein U; Neuberg DS; Bollag G; Shipp MA; Aguiar RC
    Blood; 2005 Jan; 105(1):308-16. PubMed ID: 15331441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phosphodiesterase 4B-dependent interplay between tumor cells and the microenvironment regulates angiogenesis in B-cell lymphoma.
    Suhasini AN; Wang L; Holder KN; Lin AP; Bhatnagar H; Kim SW; Moritz AW; Aguiar RCT
    Leukemia; 2016 Mar; 30(3):617-626. PubMed ID: 26503641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
    Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
    Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational combined targeting of phosphodiesterase 4B and SYK in DLBCL.
    Kim SW; Rai D; McKeller MR; Aguiar RC
    Blood; 2009 Jun; 113(24):6153-60. PubMed ID: 19369227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the Myc-PDE4B regulatory circuitry impairs B-cell lymphoma survival.
    Nam J; Kim DU; Kim E; Kwak B; Ko MJ; Oh AY; Park BJ; Kim YW; Kim A; Sun H; Jung Y; Lee JH; Shin HJ; Park I; Song DK; Jeong JY; Lee YH; Kim SW
    Leukemia; 2019 Dec; 33(12):2912-2923. PubMed ID: 31138843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-α and cAMP/PKA pathways.
    Lv M; Zhang X; Jia H; Li D; Zhang B; Zhang H; Hong M; Jiang T; Jiang Q; Lu J; Huang X; Huang B
    Leukemia; 2012 Apr; 26(4):769-77. PubMed ID: 21979877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells.
    Janaki Ramaiah M; Lavanya A; Honarpisheh M; Zarea M; Bhadra U; Bhadra MP
    Gene; 2014 Dec; 552(2):255-64. PubMed ID: 25261849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor.
    Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB
    J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab.
    Xu ZZ; Xia ZG; Wang AH; Wang WF; Liu ZY; Chen LY; Li JM
    Ann Hematol; 2013 Oct; 92(10):1351-8. PubMed ID: 23636313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfasalazine sensitises human monocytic/macrophage cells for glucocorticoids by upregulation of glucocorticoid receptor alpha and glucocorticoid induced apoptosis.
    Oerlemans R; Vink J; Dijkmans BA; Assaraf YG; van Miltenburg M; van der Heijden J; Ifergan I; Lems WF; Scheper RJ; Kaspers GJ; Cloos J; Jansen G
    Ann Rheum Dis; 2007 Oct; 66(10):1289-95. PubMed ID: 17267514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.
    Cui W; Zhang S; Shan C; Zhou L; Zhou Z
    FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of microRNAs on glucocorticoid responsiveness.
    Wang H; Gou X; Jiang T; Ouyang J
    J Cancer Res Clin Oncol; 2017 Jun; 143(6):1005-1011. PubMed ID: 28286901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma.
    Huang X; Shen Y; Liu M; Bi C; Jiang C; Iqbal J; McKeithan TW; Chan WC; Ding SJ; Fu K
    Am J Pathol; 2012 Jul; 181(1):26-33. PubMed ID: 22609116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of miR-21 induces biological and behavioral alterations in diffuse large B-cell lymphoma.
    Gu L; Song G; Chen L; Nie Z; He B; Pan Y; Xu Y; Li R; Gao T; Cho WC; Wang S
    Acta Haematol; 2013; 130(2):87-94. PubMed ID: 23548551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
    Fang Y; Xue JL; Shen Q; Chen J; Tian L
    Hepatology; 2012 Jun; 55(6):1852-62. PubMed ID: 22234835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticosteroid resistance in sepsis is influenced by microRNA-124--induced downregulation of glucocorticoid receptor-α.
    Ledderose C; Möhnle P; Limbeck E; Schütz S; Weis F; Rink J; Briegel J; Kreth S
    Crit Care Med; 2012 Oct; 40(10):2745-53. PubMed ID: 22846781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.